Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells

References

• Pettengell R, Morgenstern GR, Woll PJ et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993;82:3770–7.
   PubMed Web of Science ®Google Scholar
• Passos-Coelho JL, Braine HG, Davis JM et al. Predictive factorsfor peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granu-locyte-macrophage colony-stimulating factor mobilization. Clin Oncol 1995;13:705–14.
   Web of Science ®Google Scholar
• Hansson M, Svensson A, Engervall P et al. Increase of monocytespredicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration. Eur Haematol 1995;54:321 — 8.
   PubMed Web of Science ®Google Scholar
• Schots R, Van RI, Damiaens S et al. The absolute number of circulating CD34± cells predicts the number of hematopoietic stem cells that can be collected by apheresis. Bone Marrow Transplant 1996;17:509— 15.
   PubMed Web of Science ®Google Scholar
• Elliott C, Samson DM, Armitage S et al. When to harvest peripheral-blood stem cells after mobilization therapy: predic-tion of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. 7 Clin Oncol 1996;14:970— 3.
   PubMed Web of Science ®Google Scholar
• Keung YK, Cobos E, Dunn D et al. Determining factors for theoutcome of peripheral blood progenitor cells harvests. 7 Clin Apheresis 1996;11:23–6.
   PubMed Web of Science ®Google Scholar
• Schwella N, Beyer J, Schwaner I et al. Impact of preleukapher-esis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose che-motherapy in patients with germ cell cancer. 7 Clin Oncol 1996;14:1114–21.
   PubMed Web of Science ®Google Scholar
• Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSE Leuk Res 1997;21:21–7.
   Google Scholar
• Ford CD, Pace N, Lehman C. Factors affecting the efficiency of collection of CD34-positive peripheral blood cells by a blood cell separator. Transfusion 1998;38: 1046–50.
   Google Scholar
• Alcorn MJ, Farrell E, Barr J et al. The number of CD34 ± cellsmobilized into the peripheral blood can predict the quality of subsequent collections. 7 Hematother Stem Cell Res 2000;9:89–93.
   PubMedGoogle Scholar
• Rowley SD, Yu J, Gooley T et al. Trafficking of CD34 ± cells intothe peripheral circulation during collection of peripheral blood stem cells by apheresis. Bone Marrow Transplant 2001;28:649— 56.
   PubMed Web of Science ®Google Scholar
• Yu J, Leisenring W, Fritschle W et al. Enumeration of HPC in mobilized peripheral blood with the Sysmex 5E9500 predicts final CD34± cell yield in the apheresis collection. Bone Marrow Transplant 2000;25:1157–64.
   PubMed Web of Science ®Google Scholar
• Noga SJ, Vogelsang GB, Miller SC et al. Using point-of-care CD34 enumeration to optimize PBSC collection conditions. Cytotherapy 2001;3:11— 8.
   PubMed Web of Science ®Google Scholar
• Trickett AE, Smith S, Kwan YL. Accurate calculation of bloodvolume to be processed by apheresis to achieve target CD34± cell numbers for PBPC transplantation. Cytotberapy 2001;3: 5— 10.
   Google Scholar
• Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1997;20:587–91.
   PubMed Web of Science ®Google Scholar
• Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787–94.
   PubMed Web of Science ®Google Scholar
• Svensson A, Engervall P, Soderstrom T, Hansson M. PBSC harvests individually optimized by using pre-collection CD34(± ) values and on-line flow cytometric analysis of the mononuclear cell enrichment. Cytotherapy 1999;1:165— 74.
   PubMed Web of Science ®Google Scholar
• Benjamin RJ, Linsley L, Fountain D et al. Preapheresis peripheral blood CD34± mononuclear cell counts as predictors of progenitor cell yield. Transfusion 1997;37:79— 85.
   PubMed Web of Science ®Google Scholar
• Hester J, Bojko P, Rondon G, Champlin R. Integration of biological, procedural, apheresis principles of peripheral blood stem cell transplantation programs. Transfus Sci 1996;17:585–90.
   PubMedGoogle Scholar
• Menichella G, Lai M, Serafini R et al. Large volume leukapher-esis for collecting hemopoietic progenitors: role of CD 34 ± precount in predicting successful collection. Int 7 Artif Organs 1999;22:334 — 41.
   PubMed Web of Science ®Google Scholar
• Papadopoulos KP, Ayello J, Tugulea S et al. Harvest quality andfactors affecting collection and engraftment of CD34± cells in patients with breast cancer scheduled for high-dose chemother-apy and peripheral blood progenitor cell support. 7 Hematother 1997;6:61— 8.
   PubMedGoogle Scholar
• de Fabritiis P, Gonzalez M, Meloni G et al. Monitoring of CD34± cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells. Bone Marrow Transplant 1999;23:1229— 36.
   PubMed Web of Science ®Google Scholar
• Meisenberg B, Brehm T, Schmeckel A et al. A combination of low-dose cyclophosphamide and colony-stimulating factors is more cost-effective than granulocyte-colony-stimulating factors alone in mobilizing peripheral blood stem and progenitor cells. Transfusion 1998;38:209— 15.
   PubMed Web of Science ®Google Scholar
• Linker CA, Damon LE, Ries CA et al. Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone Marrow Transplant 2002;29:297–301.
   PubMed Web of Science ®Google Scholar
• Fleming DR, Goldsmith J, Goldsmith GH et al. Mobilization ofperipheral blood stem cells in high-risk breast cancer patients using G-CSF after standard dose docetaxel. 7 Hematother Stem Cell Res 2000;9:855–60.
   PubMedGoogle Scholar
• Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34± cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. Hematother 1996;5:213–26.
   PubMedGoogle Scholar
• Bojko P, Stellberg W, Kudde C et al. Kinetic study of CD34± cells during peripheral blood stem cell collections. Clin Apheresic 1999;14:18 — 25.
   PubMed Web of Science ®Google Scholar
• Ford CD, Greenwood J, Strupp A, Lehman CM. Change in CD34± cell concentration during peripheral blood progenitor cell collection: effects on collection efficiency and efficacy. Transfusion 2002;42:904— 11.
   PubMed Web of Science ®Google Scholar
• Cull G, Ivey J, Chase P et al. Collection and recruitment of CD34± cells during large-volume leukapheresis. 7 Hematother 1997;6:309— 14.
   PubMedGoogle Scholar
• Humpe A, Riggert J, Munzel U et al. A prospective, randomized,sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion 1999;39:1120— 7.
   PubMed Web of Science ®Google Scholar
• Ford CD, Chan KJ, Reilly WF, Petersen FB. An evaluation of predictive factors for CD34± cell harvest yields from patients mobilized with chemotherapy and growth factors. Transfusion 2003;43:622— 5.
   PubMed Web of Science ®Google Scholar